FDA Investigator Dogbeda F Mackenzie

Dogbeda F Mackenzie has conducted inspections on 25 sites in 4 countries as of 03 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
25
Last Inspection Date:
03 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Korea (Republic of), India, Singapore
FDA Investigators that have inspected at least one site in common with Dogbeda F Mackenzie:
Alan L Truong, Alexandria L Capuano, Alicia M Mozzachio, Amanda L Fyles, Amir Alavi, Anastasia M Shields, Anderson, Andrew K Haack, PhD, Anita Narula, PhD, Arsen Karapetyan, Bichsa T Tran, Binh T Nguyen, Brian J Ryan, Bryan A Galvez, Bryan L Mcguckin, Carla J Lundi, Caroline H Le, Carrie A Hughes, Caryn M Mcnab, Cathleen A Carr Sharpe, Cecilia H Kieu, Chelsea N Sealey, Christopher D Washington, Christopher M Jenner, Christopher R Czajka, Darren S Brown, Deborah A Greco, Deborah Schmiel, PhD, Diane Cvan Leeuwen, Diane L Raccasi, Diane R Weidley, Donna Mwilliams Hill, PhD, Douglas A Campbell, Dr. Chunchang Fang, Dr. Ralph M Bernstein, PhD, Edith M Gonzalez, Eileen A Liu, Elaine A Bunch, Ephrem Hunde, PhD, Eric C Fox, Eugene Y Chang, Evelyn Wong, Gary R Wong, Gene D Arcy, Grace E Mcnally, Greg K Keshishyan, Gunneet Kaur, Heidy C Perales, Hyung Yul Lee, Isabel Y Espinosa, Jacek Cieslak, PhD, Jacob G Lutz, James B Arnett, James R Fleckenstein, Jamie L Dion, Janet Pulver, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer M Gogley, Joan M Cantellops Figueroa, Joel D Hustedt, Joey V Quitania, John A Gonzalez, John L Stevens, Jolanna A Norton, June P Page, Ka L Wong, Kathleen S Tormey, Keeshunna D Daniels, Keith P Iams, Kelley, Kelvin X Sanders, Kevin Lee, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kirtida Patel, Kouros Kangarli, Kristin M Abaonza, Lakecha N Lewis, Lance A Finnical, Lance Mde Souza, MBA, Lanita F Kelley, Laurel A Beer, Leonard H Lavi, Linda Linh N Adams, Linda M Cheny, Linda Thai, Lucila B Nwatu, Luis P Torres, Madushini Dharmasena, PhD, Marcus F Yambot, Maria Cruz Fisher, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marion Michaelis, Mariza M Jafary, Mary Jeanet Mcgarry, Matthew B Casale, Matthew J Johnson, Matthew M Vernon, Matthew R Clabeaux, Melanie M Walker, Melinda Lee, Michael D Garcia, Michael J Kuchta, Michael Shanks, MS, Michael T Cyrus, Michelle Yclark Stuart, Miguel A Martinez Perez, Monica Commerford, PhD, Monica Markovski, PhD, Nabeela J Chaudhry, Nancy E Byerly, Nayan J Patel, Nelly N Tran, Nicholas L Hunt, Nicholas Z Lu, Patrick J Lynch, Peter E Baker, Phillip Angart, PhD, Prabhu P Raju, Rachel C Stanton, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Richmond K Yip, Riley C Myers, PhD, Rowena S Nguyen, Ryan J Borges, Saied A Asbagh, Sandra A Boyd, Sandra L Shire, DMD, MPA, Sara H Gabel, Sarah Arden, Sarah Kennett, PhD, Sean P Desbrow, Selene T Torres, Sidonie J Takougang, Sonia R Peterson, Stacie A Woods, Stephanie A Slater, MS, Steven Fong, MS, PhD, Sundy V Sedwick, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Teresa T Cain, Terrance L Thomas, Terri L Dodds, Thao T Kwan, Thao X Tran, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tracey T Duong, Tracy Denison, PhD, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vashti E Bocker, Vickie L Anderson, Vicky L Cruz, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Walden H Lee, Wayne E Seifert, Wenzheng Wendy Zhang, William V Millar, Yasamin Ameri, Yun Wu, PhD, Yvette Mlacour Davis, Zachary A Bogorad, Zhong Li, PhD

Dogbeda F Mackenzie's Documents

Publish Date Document Type Title
June, 2021 EIR Cosmetic Enterprises Ltd - EIR, 2021-06-11
May, 2021 FDA 483 BRENNTAG PACIFIC, INC. - Form 483, 2021-05-06
June, 2021 FDA 483 Cosmetic Enterprises Ltd - Form 483, 2021-06-11
June, 2021 FDA 483 CUSTOM RESEARCH LABS INC - Form 483, 2021-06-04
March, 2021 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2021-03-12
December, 2021 EIR Gilead Sciences, Inc. - EIR, 2021-12-17
October, 2021 FDA 483 AIRGAS USA, LLC - Form 483, 2021-10-29
December, 2023 FDA 483 B. Braun Medical Inc. - Form 483, 2023-12-15
September, 2023 FDA 483 Alcon Singapore Manufacturing Pte. Ltd. - Form 483, 2023-09-08
May, 2022 FDA 483 Levlad, LLC - Form 483, 2022-05-19
July, 2023 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2023-07-31
September, 2023 FDA 483 Samsung Biologics Co., Ltd. - Form 483, 2023-09-01
March, 2021 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2021-03-12
December, 2021 FDA 483 Gilead Sciences, Inc. - Form 483, 2021-12-17
March, 2022 FDA 483 West Coast Cosmetics Inc - Form 483, 2022-03-09
April, 2021 FDA 483 Cosmetic Group USA, Inc. - Form 483, 2021-04-14
October, 2021 FDA 483 Bioelements, Inc. - Form 483, 2021-10-27
March, 2021 FDA 483 Response SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483R, 2021-04-01
December, 2022 FDA 483 NeilMed Pharmaceuticals, Inc - Form 483, 2022-12-02
January, 2024 FDA 483 Optikem International, Inc. - Form 483, 2024-01-26
November, 2023 FDA 483 Norman, Fox & Co. - Form 483, 2023-11-03
August, 2022 FDA 483 Azzur Labs - San Diego LLC - Form 483, 2022-08-19
June, 2024 FDA 483 STYRAX LIFE SCIENCES PRIVATE LIMITED - Form 483, 2024-06-07
August, 2024 FDA 483 Empower Clinic Services LLC dba Empower Pharmacy - Form 483, 2024-08-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more